Professor Kenneth Oye speaks with WBUR’s Sacha Pfeiffer about his recent research that details a new way to alter the genomes of organisms and the need for a public discussion about the potential implications and benefits of this new technology.
Wall Street Journal reporter Ed Silverman interviews Professor Andrew Lo about his proposal that a public-private partnership could solve funding issues for drugs research and development. “Right now, the risk of failure [in developing an Alzheimer’s treatment] is far too high for any single pharmaceutical company to take on,” Lo explains.
Jeffrey Brown of the PBS News Hour speaks with Professor Craig Wilder about the recent $40 million settlement received by five black and Latino men wrongly convicted of rape and assault in New York City 25 years ago.
“Based on the current rates of success in creating new drugs for Alzheimer's disease, it could take 260 years until the next one is approved,” writes The Boston Globe’s Carolyn Johnson on the rationale for why Professor Andrew Lo is proposing a new, portfolio-based approach to Alzheimer's research.